- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg sponsoreret af Institute for Drug Development
I alt 733 resultater
-
Global Alliance for TB Drug DevelopmentAfsluttetTuberkulose | Tuberkulose, lunge | Tuberkulose, multiresistent | Tuberkulose, MDR | Lægemiddelresistent tuberkuloseTanzania, Georgien, Den Russiske Føderation, Brasilien, Malaysia, Filippinerne, Sydafrika, Uganda
-
Global Alliance for TB Drug DevelopmentAfsluttetTuberkulose | Tuberkulose, lungeForenede Stater
-
Global Alliance for TB Drug DevelopmentAfsluttetTuberkulose | Tuberkulose, lungeForenede Stater
-
Global Alliance for TB Drug DevelopmentAfsluttetMulti-drug Resistent TuberkuloseForenede Stater
-
Global Alliance for TB Drug DevelopmentAfsluttet
-
Global Alliance for TB Drug DevelopmentAfsluttetTuberkulose | Tuberkulose, lungeForenede Stater
-
Global Alliance for TB Drug DevelopmentAfsluttetLungetuberkuloseSydafrika
-
Global Alliance for TB Drug DevelopmentAfsluttet
-
Global Alliance for TB Drug DevelopmentAfsluttet
-
Global Alliance for TB Drug DevelopmentAfsluttet
-
Global Alliance for TB Drug DevelopmentAfsluttet
-
Global Alliance for TB Drug DevelopmentAfsluttet
-
Global Alliance for TB Drug DevelopmentAfsluttetTuberkulose, lunge, medicinfølsom | Tuberkulose, Pulmonal, Multi-Drug-resistentSydafrika, Zambia, Georgien, Filippinerne, Kenya, Malaysia, Tanzania, Uganda
-
Global Alliance for TB Drug DevelopmentAfsluttet
-
Global Alliance for TB Drug DevelopmentAfsluttet
-
Global Alliance for TB Drug DevelopmentAfsluttetTuberkulose | Tuberkulose, lungeForenede Stater
-
Global Alliance for TB Drug DevelopmentAfsluttetLungetuberkuloseSydafrika
-
Global Alliance for TB Drug DevelopmentAfsluttet
-
Global Alliance for TB Drug DevelopmentRekrutteringLægemiddelfølsom tuberkulose | Lungetuberkulose | Lunge-TBFilippinerne, Sydafrika, Tanzania, Georgien, Uganda
-
Global Alliance for TB Drug DevelopmentAktiv, ikke rekrutterendeTuberkulose | Tuberkulose, lunge | Tuberkulose, multiresistent | Tuberkulose, MDR | Lægemiddelresistent tuberkuloseGeorgien, Sydafrika
-
Global Alliance for TB Drug DevelopmentAfsluttetTuberkulose | Tuberkulose, lunge | Tuberkulose, multiresistent | Ekstremt lægemiddelresistent tuberkulose | Tuberkulose, MDR | XDR-TB | Præ-XDR-TBSydafrika, Den Russiske Føderation, Georgien, Moldova, Republikken
-
Global Alliance for TB Drug DevelopmentAfsluttetTuberkulose | Tuberkulose, lunge | Lungesygdom | Multiresistent tuberkulose | Lægemiddelfølsom tuberkulose | Lægemiddelresistent tuberkulose | Mycobacterium Tuberculosis InfektionForenede Stater
-
Global Alliance for TB Drug DevelopmentAfsluttetTuberkulose | Tuberkulose, lunge | Lungesygdom | Multiresistent tuberkulose | Lægemiddelfølsom tuberkulose | Lægemiddelresistent tuberkulose | Mycobacterium Tuberculosis InfektionForenede Stater
-
Global Alliance for TB Drug DevelopmentAfsluttet
-
Global Alliance for TB Drug DevelopmentAfsluttetTuberkuloseForenede Stater
-
Global Alliance for TB Drug DevelopmentAfsluttet
-
Global Alliance for TB Drug DevelopmentAfsluttet
-
Global Alliance for TB Drug DevelopmentAfsluttetLungetuberkuloseSydafrika
-
Tools4PatientInternational Drug Development InstituteAfsluttetSlidgigt | Perifere neuropatierFrankrig, Belgien
-
Drugs for Neglected DiseasesPhinC DevelopmentAfsluttet
-
iSTAR MedicalInternational Drug Development InstituteAktiv, ikke rekrutterendeGrøn stær, åbenvinklet glaukom øjeIndien, Panama
-
TyrogenexInternational Drug Development Institute; SynteractHCRAfsluttetØjensygdomme | Makuladegeneration | Nethindedegeneration | Nethindesygdomme | Aldersrelateret makuladegeneration (AMD) | Eksudativ aldersrelateret makuladegeneration | AMD | Makuladegeneration, aldersrelateret, 10Forenede Stater
-
Translational Drug DevelopmentTranslational Genomics Research InstituteAktiv, ikke rekrutterendeMetastatisk pancreas ductal adenokarcinomForenede Stater
-
Global Alliance for TB Drug DevelopmentQPS Holdings LLCAfsluttet
-
Drugs for Neglected DiseasesUNITAID; French Development AgencyAfsluttetHIVUganda, Kenya, Tanzania
-
AstraZenecaPHARMO Institute for Drug Outcome ResearchAfsluttetLungebetændelse | Gastroenteritis | Anfald | Ikke at trives | Hospitalized Cases of Angioneurotic Oedema | Acute Interstitial Nephritis and ThrombocytopeniaHolland
-
AstraZenecaPHARMO Institute for Drug Outcomes ResearchAfsluttetSkizofreni | Generaliseret angstlidelse | Maniodepressiv | Større depressiv lidelse
-
Centers for Disease Control and PreventionBayer; Global Alliance for TB Drug DevelopmentAfsluttetTuberkuloseUganda, Forenede Stater, Sydafrika, Canada, Brasilien, Spanien
-
3-C Institute for Social DevelopmentAfsluttet
-
3-C Institute for Social DevelopmentAfsluttetStof-relaterede lidelserForenede Stater
-
NSABP Foundation IncGenentech, Inc.; International Drug Development InstituteAfsluttet
-
Steba Biotech S.A.International Drug Development Institute; PrimeVigilance LTDAfsluttetLavrisiko prostatakræftFrankrig
-
Steba Biotech S.A.ICON plc; International Drug Development InstituteAfsluttetKræft i prostataHolland, Spanien, Frankrig, Tyskland, Det Forenede Kongerige, Finland, Italien, Sverige
-
National Development and Research Institutes, Inc.National Institute on Drug Abuse (NIDA)UkendtStofmisbrug | OpioidmisbrugForenede Stater
-
National Development and Research Institutes, Inc.National Institute on Drug Abuse (NIDA)Ukendt
-
National Development and Research Institutes, Inc.National Institute on Drug Abuse (NIDA)UkendtHIV-infektioner | Hepatitis | Seksuelt overførte infektionerForenede Stater
-
National Development and Research Institutes, Inc.National Institute on Drug Abuse (NIDA)Afsluttet
-
3-C Institute for Social DevelopmentAfsluttetSociale færdigheder | Traume, psykologisk | Familie dysfunktionelForenede Stater
-
3-C Institute for Social DevelopmentAfsluttetDiabetes mellitus, type 1Forenede Stater
-
3-C Institute for Social DevelopmentAfsluttetNyreinsufficiens, kroniskForenede Stater